Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Shares of Scholar Rock Holding Corp (NASDAQ:SRRK) rose sharply in pre-market trading after the company announced the FDA approval of ISEMBYLD (apitegromab-mstn), the first and only muscle-targeted treatment for children and adults with Spinal Muscular Atrophy (SMA).

Scholar Rock Holding shares jumped 11.9% to $62.00 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Scinai Immunotherapeutics Ltd – ADR (NASDAQ:SCNI) gained 86.9% to $3.10 in pre-market trading
• Intercont (Cayman) Ltd (NASDAQ:NCT) gained 48.2% to $0.44 in pre-market trading after adding over 2% on Friday.
• Rum Group Inc (NASDAQ:RUM) rose 23% to $8.82 in pre-market trading. The Information reported Sunday that Anthropic signed a $13.7 billion six-year compute deal with Trump-linked Rum Group.
• Volato Group Inc (NYSE:SOAR) gained 21.8% to $0.23 in pre-market trading after falling 2% on Friday.
• Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) rose 19.3% to $9.69 in pre-market trading after the company announced it will host a conference call webcast on September 14 to discuss topline data for CANYON-1.
• VS Media Holdings Ltd (NASDAQ:VSME) rose 18.7% to $1.27  in pre-market trading after gaining 16% on Friday.
• Lianhe Sowell International Group Ltd (NASDAQ:LHSW) rose 17.7% to $0.57 in pre-market trading after dipping around 26% on Friday.
• Telix Pharmaceuticals (NASDAQ:TLX) gained 7.2% to $12.10 in pre-market trading after declining around 4% on Friday.
• John Wiley & Sons Inc (NYSE:WLY) rose 6.8% to $50.22 in pre-market trading.

Losers

• Picocela Inc – ADR (NASDAQ:PCLA) tumbled 22.9% to $7.81 in pre-market trading after gaining 4% on Friday.
• Aardvark Therapeutics Inc (NASDAQ:AARD) fell 21.3% to $4.03 in pre-market trading after gaining 2% on Friday.
• Cellectis SA (NASDAQ:CLLS) fell 19.4% to $2.50 in pre-market trading. The company’s board approved a strategic transformation to become an in vivo gene editing company focused on developing long-lasting treatments for chronic diseases.
• XORTX Therapeutics Inc (NASDAQ:XRTX) fell 14.7% to $2.00 in pre-market trading after gaining 10% on Friday. XORTX Therapeutics, last week, announced the launch of production of drug material and tablet manufacturing to support its XRx-026 program for the treatment of gout.
• MKDWELL Tech Inc (NASDAQ:MKDW) declined 13.5% to $6.71 in pre-market trading. MKDWELL Tech entered into a $100 million at-the-market offering agreement.
• Biodexa Pharmaceuticals PLC-ADR (NASDAQ:BDRX) fell 14.5% to $1.11 in pre-market trading after the company announced interim results for the six months ended June 30, 2026.
• Olema Pharmaceuticals Inc (NASDAQ:OLMA) fell 12.6% to $8.93 in pre-market trading after declining 4% on Friday.
• 3 E Network Technology Group Ltd (NASDAQ:MASK) fell 11.4% to $1.09 in pre-market trading.
• Surgepays Inc (NASDAQ:SURG) fell 10.4% to $0.16 in pre-market trading. The company last week announced the sale of its ClearLine apps engagement platform to GPO Plus for $27.5 million.
• Cheetah Net Supply Chain Service Inc (NASDAQ:CTNT) fell 9.5% to $1.05 in pre-market trading after dropping 8% on Friday.

Photo via Shutterstock